Cork Woman’s Huntington’s Disease Breakthrough
- For the first time, a gene therapy trial has demonstrated successful treatment for Huntington's disease, a devastating, inherited neurodegenerative disorder.
- Éadaoin Berkeley, a 38-year-old woman diagnosed wiht Huntington's disease just 18 months ago, participated in the trial and expressed optimism about the results.
- Huntington's disease is a progressive brain disorder caused by a defective gene.
“`html
Gene Therapy Shows Promise in First Accomplished Huntington’s Disease Treatment
Table of Contents
What Happened?
For the first time, a gene therapy trial has demonstrated successful treatment for Huntington’s disease, a devastating, inherited neurodegenerative disorder. The breakthrough offers a potential path toward slowing or halting the progression of the disease, which currently has no cure.
Éadaoin Berkeley, a 38-year-old woman diagnosed wiht Huntington’s disease just 18 months ago, participated in the trial and expressed optimism about the results. “I think it’s really good news and a great success story for myself and others in the Huntington’s community,” she stated, adding that “Having hope is really crucial for the future.” She hopes the therapy will improve the quality of life for those affected and potentially lessen the severity of the illness.

Understanding Huntington’s Disease
Huntington’s disease is a progressive brain disorder caused by a defective gene. This gene leads to the breakdown of nerve cells in the brain, resulting in movement, cognitive, and psychiatric symptoms. Symptoms typically appear between ages 30 and 50, but can start earlier or later.
Key symptoms include:
- Movement Disorders: Involuntary jerking or writhing movements (chorea), rigidity, slow or abnormal eye movements, impaired gait and posture.
- Cognitive Impairments: Difficulty organizing, prioritizing, and focusing; lack of impulse control; difficulty learning new information.
- Psychiatric Disorders: Depression, irritability, obsessive-compulsive behavior, and social withdrawal.
The disease is inherited, meaning a child of a parent with Huntington’s disease has a 50% chance of inheriting the gene and developing the condition. There are approximately 30,000 people with Huntington’s disease in the United States alone, and many more are at risk. Huntington’s Disease Society of America provides comprehensive information about the disease.
| Country | Estimated Prevalence (Directly Affected) | Estimated At-Risk Family Members |
|---|---|---|
| Ireland | ~1,100 | ~3,000 |
| United states | ~30,000 | ~150,000 |
| Worldwide | ~140,000 | ~700,000 |
The Gene Therapy Breakthrough
Details of the gene therapy trial are still emerging, but the approach involves using a viral vector to deliver a gene-silencing compound to the brain. This compound aims to reduce the production of the mutant huntingtin protein, which is the root cause of
